BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 20, 2011
View Archived Issues
Abiraterone acetate plus prednisone provides clinical benefit in metastatic CRPC
Read More
New RAC-alpha serine/threonine-protein kinase inhibitors claimed
Read More
Novel PI3K-gamma inhibitors synthesized at Taisho
Read More
Stem cell therapy shows promise to treat diabetic retinopathy and optical neuropathy
Read More
Critical Outcome Technologies begins development of oral COTI-2 formulation
Read More
Armodafinil improves severe sleepiness in subjects with shift work disorder
Read More
Chemical genetics screening platform identifies new agent and target for influenza therapy
Read More
New liver X receptor agonists described by Merck & Co.
Read More
New tyrosine-protein kinase JAK3 inhibitors patented by Palau Pharma
Read More
Isis begins phase I trial of ISIS-TTRRx for transthyretin amyloidosis
Read More
Zydus-Cadila presents new peptidomimetic GLP-1 agonists/glucagon receptor antagonists
Read More
BAY-94-8862 enters phase II trial in patients with chronic heart failure and kidney disease
Read More
Medistem completes preclinical animal safety studies requested by FDA
Read More
Allergan patents novel alpha2C-adrenoceptor agonists
Read More
Resolve Therapeutics raises funds in series A financing round, plans next step for RSLV-125
Read More
Northwest Biotherapeutics and Fraunhofer enter partnership for DCVax-L
Read More
Ludwig Institute for Cancer Research and Polaris Pharmaceuticals form collaboration
Read More
FDA places new restrictions on use of rosiglitazone-containing medicines
Read More
TheraVida begins phase II trial of THVD-201
Read More
Japanese authorities approve additional indications for Novastan and Slonnon
Read More
Daiichi Sankyo's Rifadin approved for additional indication in Japan
Read More
Cell Therapeutics to meet with FDA next month regarding resubmission of pixantrone NDA
Read More
Eisai receives Japanese approval for additional indication of Vasolan formulations
Read More
Enzon Pharmaceuticals discontinues PEG-SN38 program in colorectal carcinoma
Read More
Omeros begins phase III program for OMS-103HP and OMS-302
Read More
